Inducible nitric oxide synthase is involved in endothelial dysfunction of mesenteric small arteries from hypothyroid rats

Endocrinology

Volumn 150, Issue 2, 2009, Pages 1033-1042

  Virdis, Agostino ^a   Colucci, Rocchina ^a   Fornai, Matteo ^a   Polini, Antonio ^a   Daghini, Elena ^a   Duranti, Emiliano ^a   Ghisu, Narcisa ^a   Versari, Daniele ^a   Dardano, Angela ^a   Blandizzi, Corrado ^a   Taddei, Stefano ^a   Tacca, Mario Del ^a   Monzani, Fabio ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ALLOPURINOL; APOCYNIN; ASCORBIC ACID; CYTOKINE; HYDROETHIDINE; INDUCIBLE NITRIC OXIDE SYNTHASE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE INHIBITOR; PLACEBO; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; S METHYLISOTHLOUREA; SUPEROXIDE; THIAMAZOLE; THYROTROPIN; THYROXINE; UNCLASSIFIED DRUG; XANTHINE OXIDASE;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENZYME INHIBITION; EUTHYROIDISM; HORMONE BLOOD LEVEL; HYPOTHYROIDISM; INFLAMMATION; MALE; MESENTERIC ARTERY; MYOGRAPHY; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; STAINING; UPREGULATION; VASODILATATION;

ALLOPURINOL; ANIMALS; ASCORBIC ACID; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; HYPOTHYROIDISM; MALE; MESENTERIC ARTERIES; METHIMAZOLE; NADPH OXIDASE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, WISTAR; SUPEROXIDES; THYROXINE; VASODILATION;

EID: 59649119849     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2008-1112     Document Type: Article

References (33)

1. Feletou M, Vanhoutte PM 2006 Endothelial dysfunction: a multifaceted disorder. Am J Physiol Heart Circ Physiol 291:H985-H1002
2. Taddei S, Virdis A, Ghiadoni L, Salvetti G, Bernini G, Magagna A, Salvetti A 2001 Age-related reduction of NO availability and oxidative stress in humans. Hypertension 38:274-279
3. Oudot A, Martin C, Busseuil D, Vergely C, Demaison L, Rochette L 2006 NADPH oxidases are in part responsible for increased cardiovascular super- oxide production during aging. Free Radic Biol Med 40:2214-2222
4. Busse R, Mulsch A 1990 Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. FEBS Lett 275:87-90
5. Kessler P, Bauersachs J, Busse R, Schini-KerthVB 1997 Inhibition ofinducible nitric oxide synthase restores endothelium-dependent relaxations in proin- flammatory mediator-induced blood vessels. Arterioscler Thromb Vasc Biol 17:1746 -1755
6. Ross R 1999 Atherosclerosis - an inflammatory disease. N Engl J Med 340: 115-126
7. Lerman A, Zeiher AM 2005 Endothelial function: cardiac events. Circulation 111:363-368
8. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC 2000 The Colorado thyroid disease prevalence study. Arch Intern Med 160:526-534
9. Cappola AR, Ladenson PW 2003 Hypothyroidism and atherosclerosis. J Clin Endocrinol Metab 88:2438 -2444
10. Delp MD, McAllister RM, Laughlin MH 1995 Exercise training alters aortic vascular reactivity in hypothyroid rats. Am J Physiol 268:H1428-H1435
11. McAllister RM, Luther KL, Pfeifer PC 2000 Thyroid status and response to endothelin-1 in rat arterial vessels. Am J Physiol Endocrinol Metab 279:E252-E258
12. Vargas F, Fernandez-Rivas A, Garcia Estan J, Garcia del Rio C 1995 Endo- the lium-dependent and endothelium-independent vasodilation in hyperthy- roid and hypothyroid rats. Pharmacology 51:308-314
13. Quesada A, Sainz J, Wangensteen R, Rodriguez-Gomez I, Vargas F, Osuna A 2002 Nitric oxide synthase activity in hyperthyroid and hypothyroid rats. Eur J Endocrinol 147:117-122
14. Takiguchi Y, Satoh N, Hashimoto H, Nakashima M 1988 Changes in vascular reactivity in experimental diabetic rats: comparison with hypothyroid rats. Blood Vessels 25:250-260
15. Virdis A, Colucci R, Fornai M, Blandizzi C, Duranti E, Pinto S, Bernardini N, Segnani C, Antonioli L, Taddei S, Salvetti A, Del Tacca M 2005 Cyclooxy- genase-2 inhibition improves vascular endothelial dysfunction in a rat model of endotoxic shock: role ofinducible nitric-oxide synthase and oxidative stress. J Pharmacol Exp Ther 312:945-953
16. Virdis A, Colucci R, Fornai M, Duranti E, Giannarelli C, Bernardini N, SegnaniC, Ippolito C, AntonioliL, BlandizziC, TaddeiS, SalvettiA, DelTacca M2007 Cyclooxygenase-1 is involved in endothelial dysfunction of mesenteric small arteries from angiotensin II-infused mice. Hypertension 49:679-686
17. Schultz K, Schultz G 1977 Sodium nitroprusside and other smooth muscle- relaxants increase cyclic GMP levels in rat ductus deferens. Nature 265:750751
18. Boer R, Ulrich WR, Klein T, Mirau B, Haas S, Baur I 2000 The inhibitory potency and selectivity of arginine substrate site nitric-oxide synthase inhibitors is solely determined by their affinity toward the different isoenzymes. Mol Pharmacol 58:1026-1034
19. Muntane J, Rodriguez FJ, Segado O, Quintero A, Lozano JM, Siendones E, Pedraza CA, Delgado M, O'Valle F, Garcia R, Montero JL, De La Mata M, Mino G 2000 TNF-α dependent production of inducible nitric oxide is involved in PGE(1) protection against acute liver injury. Gut 47:553-562
20. Beswick RA, Dorrance AM, Leite R, Webb RC 2001 NADH/NADPH oxidase and enhanced superoxide production in the mineralocorticoid hypertensive rat. Hypertension 38:1107-1111
21. Virdis A, Iglarz M, Neves MF, Amiri F, Touyz RM, Rozen R, Schiffrin EL 2003 Effect of hyperhomocystinemia and hypertension on endothelial function in methylenetetrahydrofolate reductase-deficient mice. Arterioscler Thromb Vasc Biol 23:1352-1357
22. Versari D, Daghini E, Rodriguez-Porcel M, Sattler K, Galili O, Pilarczyk K, Napoli C, Lerman LO, Lerman A 2006 Chronic antioxidant supplementation impairs coronary endothelial function and myocardial perfusion in normal pigs. Hypertension 47:475-481
23. Owen PJ, Ying H, Lang D, Tomlinson D, Lewis MJ, Cheng SY, Lazarus JH 2007 Endothelial dysfunction in a murine model of thyroid hormone resistance. Eur J Clin Invest 37:390-395
24. Antunes TT, Gagnon A, Bell A, Sorisky A 2005 Thyroid-stimulating hormone stimulates interleukin-6 release from 3T3-L1 adipocytes through a cAMP- protein kinase A pathway. Obes Res 13:2066-2071
25. Schwedler SB, Kuhlencordt PJ, Ponnuswamy PP, Hatiboglu G, Quaschning T, Widder J, Wanner C, Potempa LA, Galle J 2007 Native C-reactive protein induces endothelial dysfunction in ApoE(-/-) mice: Implications for iNOS and reactive oxygen species. Atherosclerosis 195:e76-e84
26. Donnini D, Ambesi-Impiombato FS, Curcio F 2003 Thyrotropin stimulates production of procoagulant and vasodilative factors in human aortic endo-thelial cells. Thyroid 13:517-521
27. Taddei S, Caraccio N, Virdis A, Dardano A, Versari D, Ghiadoni L, Ferrannini E, Salvetti A, Monzani F 2006 Low-grade systemic inflammation causes en- dothelial dysfunction in patients with Hashimoto's thyroiditis. J Clin Endo-crinol Metab 91:5076-5082
28. Napoli R, Biondi B, Guardasole V, D'Anna C, De Sena A, Pirozzi C, Terracciano D, Mazzarella C, Matarazzo M, Sacca L 2008 Enhancement of vascular endothelial function by recombinant human thyrotropin. J Clin Endocrinol Metab 93:1959-1963
29. Bussemaker E, Popp R, Fisslthaler B, Larson CM, Fleming I, Busse R, Brandes RP 2003 Hyperthyroidism enhances endothelium-dependent relaxation in the rat renal artery. Cardiovasc Res 59:181-188
30. Grieve DJ, Fletcher S, Pitsillides AA, Botham KM, Elliott J 1999 Effects of oral propylthiouracil treatment on nitric oxide production in rat aorta. Br J Pharmacol 127:1-8
31. Xia Y, Roman LJ, Masters BS, Zweier JL 1998 Inducible nitric-oxide synthase generates superoxide from thereductase domain. J Biol Chem 273:22635-22639
32. Wilcox JN, Subramanian RR, Sundell CL, Tracey WR, Pollock JS, Harrison DG, MarsdenPA1997 Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels. Arterioscler Thromb Vasc Biol 17:2479-2488
33. Hornig B, Landmesser U, Kohler C, Ahlersmann D, Spiekermann S, Christoph A, Tatge H, Drexler H 2001 Comparative effect of ace inhibition and angio- tensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease: role of superoxide dismutase. Circulation 103:799-805